BREAKING: Limerick jobs boost as Eli Lilly confirm 150 new positions
$1bn expansion of Limerick facility
ELI Lilly and Company has announced a $1bn expansion of its Limerick facility, 150 new jobs and is doubling the firm’s investment in Raheen.
Today's announcement brings Lilly's total Limerick investment to $2bn, doubling the investment the company announced in March of 2023.
As a part of this expansion, Lilly will create another 150 jobs for highly skilled workers in Limerick such as engineers, scientists, quality assurance professionals and operations personnel, for a total of 450 employees.
Lilly initially announced the Limerick site in 2022 and broke ground in March 2023. Production of biologic active ingredients for Lilly medicines is on track to start in 2026.
The Limerick investment project is subject to planning approval, and the company will submit a planning application to the Limerick City and County Council in due course.
IDA Ireland CEO Michael Lohan said: “Today's announcement in Limerick effectively doubles down on Eli Lilly and Company's 2022 announcement to build a new manufacturing facility in Raheen.”
Once complete, Limerick will join Lill's global manufacturing network producing the biologic active ingredients for the company's Alzheimer's disease portfolio and other biologic medicines.
A new greenfield manufacturing investment in Raheen, Limerick was announced by Lilly in 2022. The state-of-the-art campus is under construction and on track to begin manufacturing in 2026.
Once completed, the Limerick site will operate with 35% lower energy intensity, use 40% less water, and generate 15% less waste than traditional biopharmaceutical manufacturing processes.